Announcements
- Further detail from G306 Phase III field trial
- Director Resignation
- Interim Results for six months ended 31 Dec 2023
- Update on funding
- VLP Peanut PROTECT Trial Update
- VLP Peanut PROTECT Trial Update
- Appointment of Shaun Furlong to Board of Directors
- Result of AGM
- Half-Year Trading Update 2024
- Notice of 2023 Annual General Meeting
More ▼
Key statistics
As of last trade Allergy Therapeutics PLC (AGYTF:PKC) traded at 0.02, 0.00% below its 52-week high of 0.02, set on Mar 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 0.02 |
Average volume | -- |
---|---|
Shares outstanding | 4.77bn |
Free float | 323.44m |
P/E (TTM) | -- |
Market cap | 162.06m GBP |
EPS (TTM) | -0.0266 GBP |
Data delayed at least 15 minutes, as of Mar 25 2024.
More ▼